Total Holdings
50
Portfolio diversification across 50 positions
GNOM
(NASDAQ)Global X Genomics & Biotechnology ETF
$44.19-- (--)
Loading... - Market loading
GNOM ETF Holdings: Global X Genomics & Biotechnology ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$49.36M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Global X
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Moderna, Inc. | Stock | 8.23% |
| 2 |  | Praxis Precision Medicines, Inc. | Stock | 6.63% |
| 3 |  | Arrowhead Pharmaceuticals, Inc | Stock | 6.51% |
| 4 |  | Guardant Health, Inc | Stock | 5.69% |
| 5 |  | Illumina, Inc. | Stock | 5.42% |
| 6 |  | BioMarin Pharmaceutical Inc. | Stock | 4.49% |
| 7 |  | Vertex Pharmaceuticals Incorporated | Stock | 4.36% |
| 8 |  | Natera, Inc | Stock | 4.30% |
| 9 |  | BioNTech SE | Stock | 3.81% |
| 10 |  | Avidity Biosciences Inc | Stock | 3.81% |
| 11 | E ETR:QIA | QIAGEN N.V | Stock | 3.80% |
| 12 |  | Bio-Techne Corporation | Stock | 3.79% |
| 13 |  | Qiagen N.V. | Stock | 3.30% |
| 14 |  | CRISPR Therapeutics AG | Stock | 3.17% |
| 15 | B BMY | Bristol-Myers Squibb Company | Stock | 2.94% |
| 16 |  | Alnylam Pharmaceuticals, Inc. | Stock | 2.77% |
| 17 |  | Twist Bioscience Corporation | Stock | 2.72% |
| 18 |  | Veracyte, Inc | Stock | 2.47% |
| 19 | L LON:AZN | AstraZeneca PLC | Stock | 2.45% |
| 20 |  | Legend Biotech Corporation | Stock | 2.41% |
| 21 |  | Gilead Sciences, Inc. | Stock | 2.41% |
| 22 |  | Eli Lilly and Company | Stock | 2.38% |
| 23 |  | 10x Genomics, Inc. | Stock | 2.32% |
| 24 |  | Beam Therapeutics Inc | Stock | 2.17% |
| 25 | L LSE:AZN | AstraZeneca PLC | Stock | 2.07% |
| 26 |  | GeneDx Holdings Corp. | Stock | 2.06% |
| 27 |  | Sarepta Therapeutics, Inc. | Stock | 1.95% |
| 28 |  | Ultragenyx Pharmaceutical Inc | Stock | 1.89% |
| 29 | H HKG:1548 | Genscript Biotech Corporation | Stock | 1.61% |
| 30 |  | Wave Life Sciences Ltd | Stock | 1.48% |
| 31 |  | uniQure N.V | Stock | 1.29% |
| 32 |  | Intellia Therapeutics, Inc | Stock | 1.13% |
| 33 |  | CareDx, Inc | Stock | 0.88% |
| 34 |  | Vir Biotechnology, Inc | Stock | 0.59% |
| 35 |  | Pacific Biosciences of California, Inc | Stock | 0.47% |
| 36 |  | Fulgent Genetics, Inc | Stock | 0.44% |
| 37 |  | REGENXBIO Inc | Stock | 0.43% |
| 38 |  | Agilent Technologies, Inc | Stock | 0.42% |
| 39 |  | Personalis, Inc | Stock | 0.42% |
| 40 |  | Myriad Genetics, Inc | Stock | 0.40% |
| 41 |  | Mesa Laboratories, Inc | Stock | 0.31% |
| 42 | F FLDM | Fluidigm Corporation | Stock | 0.31% |
| 43 |  | Prime Medicine Inc. Common Stock | Stock | 0.30% |
| 44 |  | Stoke Therapeutics, Inc | Stock | 0.29% |
| 45 |  | Maravai LifeSciences Holdings, Inc | Stock | 0.29% |
| 46 |  | Rocket Pharmaceuticals Inc | Stock | 0.25% |
| 47 |  | Sana Biotechnology, Inc | Stock | 0.22% |
| 48 |  | Arcturus Therapeutics Holdings Inc | Stock | 0.21% |
| 49 |  | Editas Medicine, Inc | Stock | 0.18% |
| 50 |  | Sangamo Therapeutics, Inc | Stock | 0.18% |
Frequently Asked Questions About Global X Genomics & Biotechnology ETF Holdings
What are the top holdings in GNOM?
Global X Genomics & Biotechnology ETF (GNOM) holds 50 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is GNOM's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review GNOM's holdings table to analyze concentration risk.
What is GNOM's sector allocation?
The Sector Allocation chart shows how GNOM distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does GNOM invest in?
GNOM's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is GNOM ETF?
GNOM's diversification can be assessed by reviewing its 50 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.